retatrutide phase 3 trial dosage 🚨 HOT OFF THE PRESS: data has arrived — and the obesity medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average Lilly's retatrutide shows 28% weight

Clinical vignette-keto diet-induced dyslipidemia and lean mass hyper-responders

Japan and South Korea are forecast to post 15.1% and 14.7% growth as convenience-led nutrition and portion-controlled formats gain more relevance

Cleveland Clinic: Leg Pain American Academy of Orthopaedic Surgeons: Burning Thigh Pain (Meralgia Paresthetica) Arthritis Foundation: Types of Pain and the Body Harvard Health Publishing: When Walking Makes Your Legs Hurt Justin Laube, MD Medical Reviewer Justin Laube, MD, is a dual board-certified integrative and internal medicine physician, retreat leader, and healing educator with over 15 years of experience caring for patients w

Our study identified hyperactive behavior and panic disorder as potential side effects of GLP1R/GIP agonists, with mood disorders impacted across all drug networks

The hypoglycemic strategy has also shifted from sugar control to both sugar control and heart protection

Investigating these potential effects in the context of antitumor treatment is crucial (Basak et al., 2023